tradingkey.logo

STRATA Skin Sciences Inc

SSKN
查看詳細走勢圖
1.270USD
+0.050+4.10%
收盤 12/24, 13:00美東報價延遲15分鐘
6.69M總市值
虧損本益比TTM

STRATA Skin Sciences Inc

1.270
+0.050+4.10%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+4.10%

5天

-2.31%

1月

-2.31%

6月

-45.49%

今年開始到現在

-56.36%

1年

-55.90%

查看詳細走勢圖

TradingKey STRATA Skin Sciences Inc股票評分

單位: USD 更新時間: 2025-12-24

操作建議

STRATA Skin Sciences Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名123/206位。機構持股佔比非常高,近一個月多位分析師給出公司評級為強力買入。最高目標價7.40。中期看,股價處於下降通道。近一個月,市場表現較差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

STRATA Skin Sciences Inc評分

相關信息

行業排名
123 / 206
全市場排名
291 / 4562
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 2 分析師
強力買入
評級
7.400
目標均價
+436.23%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

STRATA Skin Sciences Inc亮點

亮點風險
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
業績增長期
公司處於發展階段,最新年度總收入33.56M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入33.56M美元
估值高估
公司最新PE估值-0.48,處於3年歷史高位
機構減倉
最新機構持股2.60M股,環比減少6.19%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉101.53K股
活躍度增加
近期活躍度增加,過去20天平均換手率16.43

STRATA Skin Sciences Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

STRATA Skin Sciences Inc簡介

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
公司代碼SSKN
公司STRATA Skin Sciences Inc
CEORafaeli (Dolev)
網址https://www.strataskinsciences.com/

常見問題

STRATA Skin Sciences Inc(SSKN)的當前股價是多少?

STRATA Skin Sciences Inc(SSKN)的當前股價是 1.270。

STRATA Skin Sciences Inc 的股票代碼是什麼?

STRATA Skin Sciences Inc的股票代碼是SSKN。

STRATA Skin Sciences Inc股票的52週最高點是多少?

STRATA Skin Sciences Inc股票的52週最高點是3.860。

STRATA Skin Sciences Inc股票的52週最低點是多少?

STRATA Skin Sciences Inc股票的52週最低點是1.240。

STRATA Skin Sciences Inc的市值是多少?

STRATA Skin Sciences Inc的市值是6.69M。

STRATA Skin Sciences Inc的淨利潤是多少?

STRATA Skin Sciences Inc的淨利潤為-10.09M。

現在STRATA Skin Sciences Inc(SSKN)的股票是買入、持有還是賣出?

根據分析師評級,STRATA Skin Sciences Inc(SSKN)的總體評級為--,目標價格為7.400。

STRATA Skin Sciences Inc(SSKN)股票的每股收益(EPS TTM)是多少

STRATA Skin Sciences Inc(SSKN)股票的每股收益(EPS TTM)是-2.626。
KeyAI